Jamie Chang, M.D.
Jamie Chang, M.D.
Melding clinical pragmatism with scientific rigor to better plan and conduct high-quality clinical trials, Dr. Jamison Chang is a board-certified internist with over 15 years of clinical experience. While his experience includes a broad range of disease entities (both ambulatory and hospital settings), a significant portion of Dr. Chang’s clinical practice has been focused in the treatment of infectious disease patients.
Over the course of his clinical career, Dr. Chang has diagnosed and treated patients with pulmonary, soft-tissue, urinary tract, orthopedic, central nervous system, and bloodstream infections in both outpatient, acute, and critical care settings. Dr. Chang’s collective experience in infectious diseases has allowed him to more keenly understand the unmet needs within the treatment area and help sponsors design development programs around the specific needs of this target population.
Upon completion of his residency and chief residency at the University of North Carolina Chapel Hill, Dr. Chang obtained additional training in nephrology which now allows him to better understand and treat a broad range of infections in immunocompromised subjects. He also obtained a master’s degree in clinical research (MS-CR) during the course of his renal fellowship.
Prior to his tenure at Rho, Dr. Chang cared for a wide variety of patients including those with solid and hematologic malignancies, cardiovascular disease, as well as post-operative patients in his role as a hospitalist at UNC Hospital.
Why Infectious Disease?
“The science tells us that emerging pathogens are going to be the norm as humans increasingly expand their footprint across the globe. With that knowledge, the onus is on us, the medical community, to start thinking about how we might manage these infections.”
This is what drives Jamie:
“I’m actually driven by the need to help others. So when I realized that there were still a significant amount of unmet needs across many disease areas, given my clinical experience … I felt the need to share this knowledge and help develop therapies that would bring meaningful benefits to these patients.”